However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
Researchers investigate AHK-Cu because of its association with copper transport , extracellular matrix regulation, peptide-mediated signaling, connective tissue biology, and molecular communication
Our med spa provides a pristine, controlled environment that adheres to the highest standards of safety and hygiene, so you never have to worry about the risks of at-home injections
Ideal for first-time researchers or new research cycles
Excellent product I dont feel like I lost weight but I did have increased energy